Wagner Wealth Management LLC Reduces Stake in Walgreens Boots Alliance Inc (WBA)

Wagner Wealth Management LLC cut its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 25.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,953 shares of the pharmacy operator’s stock after selling 670 shares during the quarter. Wagner Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $142,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of WBA. WoodTrust Financial Corp increased its position in Walgreens Boots Alliance by 2.1% during the third quarter. WoodTrust Financial Corp now owns 31,178 shares of the pharmacy operator’s stock worth $2,273,000 after buying an additional 656 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in Walgreens Boots Alliance by 10.1% during the third quarter. Parkside Financial Bank & Trust now owns 7,649 shares of the pharmacy operator’s stock valued at $557,000 after acquiring an additional 703 shares during the period. New Potomac Partners LLC boosted its holdings in Walgreens Boots Alliance by 2.7% during the third quarter. New Potomac Partners LLC now owns 26,661 shares of the pharmacy operator’s stock valued at $1,944,000 after acquiring an additional 709 shares during the period. Acadian Asset Management LLC boosted its holdings in Walgreens Boots Alliance by 5.0% during the third quarter. Acadian Asset Management LLC now owns 15,452 shares of the pharmacy operator’s stock valued at $1,126,000 after acquiring an additional 731 shares during the period. Finally, Savant Capital LLC boosted its holdings in Walgreens Boots Alliance by 5.6% during the third quarter. Savant Capital LLC now owns 14,491 shares of the pharmacy operator’s stock valued at $1,056,000 after acquiring an additional 766 shares during the period. 64.57% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts have issued reports on the stock. Barclays upped their price target on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a report on Friday, October 12th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a report on Wednesday, September 12th. Citigroup upped their price target on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a report on Friday, October 12th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a report on Tuesday, September 25th. Finally, Robert W. Baird increased their target price on shares of Walgreens Boots Alliance from $64.00 to $69.00 and gave the company a “neutral” rating in a research note on Tuesday, September 11th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $78.22.

Shares of NASDAQ WBA traded down $0.27 during mid-day trading on Friday, hitting $82.17. The company had a trading volume of 334,398 shares, compared to its average volume of 7,898,199. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $83.00. The stock has a market cap of $76.50 billion, a PE ratio of 13.65, a PEG ratio of 1.28 and a beta of 0.74.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The business had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. Research analysts forecast that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.14%. The ex-dividend date of this dividend is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.

In other Walgreens Boots Alliance news, SVP Kimberly R. Scardino sold 11,970 shares of the firm’s stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $79.79, for a total transaction of $955,086.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction dated Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the transaction, the executive vice president now owns 81,076 shares of the company’s stock, valued at approximately $6,386,356.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 66,706 shares of company stock valued at $5,268,584. Corporate insiders own 14.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Wagner Wealth Management LLC Reduces Stake in Walgreens Boots Alliance Inc (WBA)” was reported by WKRB News and is the property of of WKRB News. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.wkrb13.com/2018/11/10/wagner-wealth-management-llc-reduces-stake-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: Trading Strategy Methods for Individual Investors

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply